Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Bone Marrow Diseases × spartalizumab × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Solid Tumors 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 ponatinib 1 pembrolizumab 1 ibrutinib 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Tacrolimus 1 Quality of Life 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Electrocardiography 1 Cyclophosphamide 1 Clinical Laboratory Techniques 1 Busulfan 1 Bone Marrow Transplantation 1 Bone Marrow Examination 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡